Cancer Community at Illinois



Cancer Community News


Cancer Community News

  • 2/27/2015
    CHAMPAIGN, Ill. — A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs with spontaneously occurring cancers, and is still in clinical trials in dogs with osteosarcoma.
  • 2/26/2015
    Announcements, events, and opportunities for members of the Cancer Community at Illinois.
  • 2/20/2015
    Nicole Rogus-Pulia, from left, of University of Wisconsin-Madison and Karin Rosenblatt of the University of Illinois at Urbana-Champaign will each be giving talks focusing on cancer topics next week. Find out more in this week's digest.
  • 2/17/2015
    A new technique being developed by Kris Kilian could revolutionize medicine by enabling a patient’s own cells to be reverted back and modified to correct mutations and regenerate injured tissues. Kilian recently received a National Science Foundation CAREER Award for this work and for his initiative in educating students about stem cell engineering.
  • 2/16/2015
    Physics professor Taekjip Ha led research to develop a new tool, called a "tension gauge tether," that allows scientists to measure cell mechanics at the single-molecule level which is crucial to understanding how they activate a wide range of cellular functions, such as cell reproduction, differentiation, and adhesion — basic physiological processes that underlie embryo development, tumor metastasis, wound healing, and other aspects of human health and disease.


ShareThis Copy and Paste